BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 75 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,142,000 | +977.4% | 76,498 | +551.0% | 0.06% | +966.7% |
| Q1 2015 | $106,000 | -45.9% | 11,751 | -26.9% | 0.01% | -62.5% |
| Q4 2014 | $196,000 | -51.7% | 16,084 | -49.6% | 0.02% | -51.5% |
| Q2 2014 | $406,000 | -38.4% | 31,882 | -48.8% | 0.03% | -71.6% |
| Q1 2014 | $659,000 | +53.3% | 62,306 | +10.2% | 0.12% | +107.1% |
| Q4 2013 | $430,000 | +101.9% | 56,551 | +93.4% | 0.06% | +40.0% |
| Q3 2013 | $213,000 | – | 29,243 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |